PharmEasy Stock Price, Funding, Valuation, Revenue & Financial …

Funding, Valuation & Revenue. 16 Fundings. PharmEasy has raised $1.785B over 16 rounds.. PharmEasy's latest funding round was a Series G - II for $216M on April 29, 2024.. …

CouponFollow Extension

$1.78
OFF

PharmEasy Stock Price, Funding, Valuation, Revenue & Financial …

1 week from now

Funding, Valuation & Revenue. 16 Fundings. PharmEasy has raised $1.785B over 16 rounds.. PharmEasy's latest funding round was a Series G - II for $216M on April 29, 2024.. …

cbinsights.com

15%
OFF

PharmEasy Halves Loss To Rs 2,533 Crore In FY24, Revenue Dips 15%

1 week from now

22 hours ago · PharmEasy published these numbers on its website. Total expenses for the year were Rs 7,255 crore, reflecting a reduction from Rs 8,974 crore in the previous year, but …

indiatimes.com

92%
OFF

PharmEasy Valuation Slashed To $458 Mn By Janus Henderson

1 week from now

Sep 3, 2024 · This is around a 92% valuation markdown from its peak of $5.6 billion in 2021. PharmEasy’s investor and global asset management company Janus Henderson slashes the …

entrackr.com

30%
OFF

Pharmeasy Operating Revenue: PharmEasy’s FY23 Operating …

1 week from now

Jan 30, 2024 · API Holdings, which runs online pharmacy PharmEasy, widened its consolidated net loss by 30% to Rs 5,212 crore in the financial year ended March though operating revenue …

indiatimes.com

51%
OFF

PharmEasy Cuts Losses By 51% To Rs 2,533 Cr In FY24, Revenue Dips …

1 week from now

1 day ago · PharmEasy’s revenue from operations shrank 14.8% to Rs 5,664 ... and Temasek, among others. It raised $216 million in funding in a down round during April this year and was …

entrackr.com

$5
OFF

PharmEasy Valued At $5.6 Billion In Pre-IPO Round

1 week from now

Oct 18, 2021 · PharmEasy valued at $5.6 billion in pre-IPO round The new round included primary funding of $205 million (Rs 1,505.89 crore) and a secondary component of $140 …

financialexpress.com

10%
OFF

PharmEasy’s Scale Crosses Rs 6,600 Cr In FY23; Losses Down 16

1 week from now

Jan 30, 2024 · As per the financial statement, out of the total revenue during FY23, Rs 775 crore pertains to four customers which contributed more than 10% of total revenue. PharmEasy also …

entrackr.com

FAQs about PharmEasy Stock Price, Funding, Valuation, Revenue & Financial … Coupon?

What is PharmEasy's current valuation?

API Holdings, the parent firm of PharmEasy, was valued at $5.6 billion in its most recent funding round in the second half of 2021. However, the startup plans to raise new financing at a valuation of 5 Indian rupees per share, down from 50 earlier. ...

How much is PharmEasy worth?

As per TheKredible’s estimates, the company has been valued at around Rs 5,904 crore or $710 million (post-allotment). This is a nearly 90% haircut in valuation of PharmEasy which was once valued at $5.6 billion in 2021. Last month, the Competition Commission of India (CCI) cleared Ranjan Pai’s investment in PharmEasy. ...

Who invested in PharmEasy?

The participants in PharmEasy's latest funding round included MEMG's family office, which contributed Rs 800 crore, while Prosus, Temasek, and 360 One Portfolios contributed Rs 221 crore, Rs 183 crore, and Rs 200 crore, respectively. CDPQ Private Equity, WSSS Investments, Goldman Sachs, and Evolution Debt Capital invested a total of Rs 400 crore. ...

How much did PharmEasy spend on operating revenue?

On a unit level, PharmEasy spent Rs 1.48 to earn a rupee of operating revenue during the same period. PharmEasy has raised over a billion dollars to date including a $217 million worth round at over $5 billion valuation in October last year. The company turned unicorn in April 2021 after raising a $350 million round led by Prosus and TPG Growth. ...

How much money did PharmEasy invest in a new round?

The new round included primary funding of $205 million (Rs 1,505.89 crore) and a secondary component of $140 million (Rs 1,054.94 crore), documents showed. An Economic Times report on Monday said PharmEasy founders Dharmil Sheth and Dr Dhaval Shah purchased secondary shares worth $40 million in the round. ...

What is PharmEasy's post-money valuation?

PharmEasy's latest post-money valuation is from April 2024. Sign up for a free demo to see PharmEasy's valuations in April 2024 and more. PharmEasy's 2023 revenue was $795.96M. PharmEasy's most recent revenue is from 2022. Sign up for a free demo to see revenue data from 2022 and more. ...